Medicare Enrolled

Dr. Alex Koper, M.D.

Urology Physician · Santa Barbara, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
215 PESETAS LN, Santa Barbara, CA 93110
8056811761
In practice since 2006 (19 years)
NPI: 1053324079 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Koper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koper? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Koper

Dr. Alex Koper is an urology physician in Santa Barbara, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Koper performed 5,155 Medicare services across 2,081 unique beneficiaries.

Between the years covered by Open Payments, Dr. Koper received a total of $3,806 from 43 pharmaceutical and/or device companies across 85 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Koper is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 19% volume in CA $3,806 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,155
Medicare services
Top 19% in CA for urology physician
2,081
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~271 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
BCG treatment for bladder cancer 2,061 $2 $7
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
846 $65 $249
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
529 $101 $353
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
412 $9 $50
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
357 $2 $7
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
157 $201 $566
Simple change of bladder tube 156 $78 $303
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
141 $86 $349
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
83 $41 $260
Leuprolide acetate (for depot suspension), 7.5 mg 79 $138 $709
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
72 $53 $204
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
53 $41 $155
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
52 $75 $294
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
33 $206 $623
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
33 $125 $409
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
27 $77 $246
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
17 $6 $215
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
17 $29 $115
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $123 $453
Waterjet prostate destruction via urethra
A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra.
14 $605 $2,521
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,806
Total received (2018-2024)
Avg $544/year across 7 years
Top 40% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
85
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,678 (96.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$128 (3.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$793
2023
$750
2022
$689
2021
$30
2020
$581
2019
$376
2018
$587

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
HISTOSONICS, INC.
$272
Medtronic, Inc.
$173
Ferring Pharmaceuticals Inc.
$122
Sumitomo Pharma America, Inc.
$106
Ambu Inc.
$62
IMMUNITYBIO, INC.
$25
Tolmar, Inc.
$17
PROCEPT BioRobotics Corporation
$16
Top 3 companies account for 71.7% of 2024 payments
All-time payments by company (2018-2024) ›
EDAP TECHNOMED INC
$410
PROCEPT BioRobotics Corporation
$326
HISTOSONICS, INC.
$272
Photocure Inc
$251
AbbVie, Inc.
$195
Progenics Pharmaceuticals, Inc.
$176
Palette Life Sciences, Inc.
$175
Medtronic, Inc.
$173
Teleflex LLC
$151
Boston Scientific Corporation
$143
Ferring Pharmaceuticals Inc.
$141
BIOTISSUE HOLDINGS, INC.
$122
ABBVIE INC.
$115
Sumitomo Pharma America, Inc.
$106
Coloplast Corp
$103
Astellas Pharma US Inc
$93
NeoTract Inc.
$85
Janssen Pharmaceuticals, Inc
$64
Ambu Inc.
$62
Rochester Medical Corporation
$56
Endo Pharmaceuticals Inc.
$54
C. R. Bard, Inc. & Subsidiaries
$46
Olympus America Inc.
$44
Avadel Specialty Pharmaceuticals, LLC
$41
Ethicon US, LLC
$36
PFIZER INC.
$33
Augmenix, Inc.
$29
AMAG Pharmaceuticals, Inc.
$25
IMMUNITYBIO, INC.
$25
Allergan Inc.
$25
UroGen Pharma, Inc.
$24
TOLMAR Pharmaceuticals, Inc.
$23
Sagent Pharmaceuticals, Inc.
$23
180 Medical, Inc.
$22
Medtronic USA, Inc.
$17
TherapeuticsMD, Inc.
$17
AbbVie Inc.
$17
Amgen Inc.
$17
Tolmar, Inc.
$17
RGH Enterprises, Inc.
$16
Foundation Medicine, Inc.
$14
Janssen Biotech, Inc.
$13
Cook Medical LLC
$11
Top 3 companies account for 26.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · AMS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AquaBeam Robotic System · BOTOX · BOTOX THERAPEUTIC · CERTUS 140 MICROWAVE ABLATION SYSTEM · CYSVIEW · Cook · Cysview · ELIGARD · EVICEL Fibrin Sealant (Human) · Erleada · FOUNDATIONONE · Glydo · IMVEXXY · INTERSTIM · INTRAROSA · JELMYTO · LITHOVUE · LUPRON DEPOT · Ligation Solutions: Weck & Horizon brands · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · NEOX · NOCDURNA · Noctiva · ORGOVYX · Olympus Laser Devices · PREMARIN · PYLARIFY · Prolia · SIGNIA · SPEEDICATH · SpaceOAR · TITAN · TOVIAZ · UroLift · UroLift System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Santa Barbara?
Compare urology physicians in the Santa Barbara area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
13
Per 100K population
2.9
County median income
$95,977
Nearest hospital
SANTA BARBARA COUNTY PSYCHIATRIC HEALTH FACILITY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Koper is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Koper experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Koper performed 2,061 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Koper receive payments from pharmaceutical companies?
Yes. Dr. Koper received a total of $3,806 from 43 companies across 85 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koper's costs compare to other urology physicians in Santa Barbara?
Dr. Koper's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →